American Conference Institute’s (ACI) Summit on Biosimilars & Innovator Biologics

Loeb & Loeb LLP is proud to announce that Partner, Ryan Hagglund, will be speaking during American Conference Institute’s (ACI) Biosimilars & Innovator Biologics Summit from June 2-3, 2025 on "Reanalyzing the Interchangeability Designation: Realizing the Benefit of Biosimilars" on June 3.

From the event website:
This event, now in year 16, unites legal, regulatory, and market leaders to tackle challenges from FDA approvals and patent cliffs to global litigation trends.

For more information, including how to register, please visit the event website.